MIMOSA Diagnostics Company
MIMOSA Diagnostics is an m-health tech startup with a novel handheld device and integrated smartphone app for image visualization of skin health. MIMOSA is bringing medical grade technology out of hospitals and into the hands of patient consumers. The value proposition for MIMOSA’s AI diagnostic data warehouse will provide metadata insights integrated with patient EMR/EHR systems. Our first commercial entry launch is in the Diabetes sector, with future expansion to follow into other therapeutic areas. MIMOSA diagnostics puts the future of skin health into your hands. The MIMOSA is one of the few handheld multispectral skin imaging devices in the healthcare industry. Our proprietary algorithms risk profile the skin in various clinical settings. Our technology will allow healthcare to be equitable, efficient, and more personalized for all.
Technology:
P4 Medicine
Industry:
AI for Longevity
Headquarters:
Toronto, Ontario, Canada
Zip:
11-50
Founded Date:
2016-08-15
Employees Number:
11-50
Funding Status:
Seed
Acquisitions Number:
6
Investors Number:
1250000
Total Funding:
1250000
Last Funding Date:
Seed
Last Funding Type:
info@mimosadiagnostics.com
Register and Claim Ownership